The Palomino Group Announces Launch of New Reimbursement and Commercialization Consulting Business
The Palomino Group announces launch of new reimbursement and commercialization consulting business.
Minneapolis, MN (PRWEB) July 31, 2007
The Palomino Group (www. palominogroup. com), a leading reimbursement and commercialization services organization, today announced the launch of its new consulting business within the healthcare arena. The company, based in Minneapolis, MN offers a full menu of reimbursement and commercialization consulting and support services targeted towards biotechnology, pharmaceutical, medical device, and other healthcare companies.
The Palomino Group is comprised of several of the most experienced senior-level professionals from the biopharmaceutical, medical device, and reimbursement consulting service sectors. Their principals have successfully launched and supported some of the most complex, innovative, and costly therapies ever to be approved, especially in the area of oncology.
“Our senior management team offers biopharmaceutical and healthcare clients a level of applied experience that is unmatched in the reimbursement and commercialization consulting marketplace,” said Charles Griffin, co-founder, principal and Managing Director of Corporate & Business Development with The Palomino Group. Our principals have built and managed highly successful commercial divisions of numerous biopharmaceutical companies and understand every facet of the needs of today’s manufacturers and their customers.”
The Palomino Group provides healthcare organizations with a practical level of experience compared to available consulting organizations, and is confident that it can better identify with the current reimbursement and commercialization needs of manufacturers. “Our team offers clients a level of leadership, proven experience, and commitment to service that is second to none. We hold ourselves to a higher standard of quality service and support for our clients,” said Jan Palmer, co-founder, principal, and Managing Director of Reimbursement Operations.
As a result of Medicare reform and the impact it has had on the healthcare industry, the biopharmaceutical and medical device industry has been forced to make significant changes to their approach to the marketplace. With the market approval of more and more technologically advanced and costly agents, the healthcare system is limiting access to certain therapies for patients, resulting in enormous challenges for manufacturers.
“Although we have observed significant advances in medicine and technology in recent years, the growing cost of delivering healthcare has resulted in difficult choices for patients, healthcare providers, payers, and manufacturers. The talent within the Palomino Group understands the key issues and challenges facing today’s healthcare industry, especially in the area of oncology. They are well positioned to help guide healthcare companies in making the right choices for the future,” said John Akscin, Vice President of Government Relations and Customer Champion with OTN.
The Palomino Group offers a variety of reimbursement and commercialization consulting support services, including:
Strategic Reimbursement Analyses Market Assessments Product Coverage Introductions Payer Advocacy Coding and Pricing Support Legislative and Policy Monitoring Advisory Board Development Reimbursement Training & Education Qualitative Reimbursement Research Launch Plan Development Pricing & Contracting Strategy Strategic Life Cycle Development Commercial Operation Design & Budgeting
About The Palomino Group
The Palomino Group is a leading service provider company that offers reimbursement and commercialization consulting services to biotechnology, pharmaceutical, medical device, and other healthcare companies. Based in Minneapolis, the company works with client healthcare companies to provide expert reimbursement and planning support for new and existing drugs, biologics, and healthcare products. The company is heavily focused within oncology and other key disease arenas. Further information about The Palomino Group is available on their website at http://www. palominogroup. com (http://www. palominogroup. com).
Contact:
Charles P. Griffin
Principal, The Palomino Group
Direct: 919.866.0411
Fax: 919.573.9404
Minneapolis Corporate Headquarters: 763.444.6525
25248 Lincoln Drive
Isanti, MN 55040
Www. palominogroup. com
# # #
